Advertisement

Menarche and Dysmenorrhea

  • Jerry R. Klein
  • Iris F. Litt

Abstract

Menarche is one of the more dramatic signs of female puberty. It occurs late in puberty; for example, menarche occurs during Tanner Stage 4 in two-thirds of females, and in another stage for the other one-third. Tanner staging or classification of sex maturity rating is the clinical determination of secondary sex characteristics for ascertaining developmental age (see Daniel, Chapter 3). Staging of secondary sex characteristics is a relatively convenient and practical method for determining developmental age. Developmental age is superior to chronological age as a predictor for many hormonal, biochemical, and behavioral characteristics during adolescence (Gross and Duke, 1980; Rauh, 1976).

Keywords

Mefenamic Acid Ovulatory Cycle School Absence Primary Dysmenorrhea Prostaglandin Inhibitor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Anderson, A. B. M., Guillebaud, J., Haynes, P. J., and Turnbull, A. C. Reduction of menstrual blood loss by prostaglandin synthetase inhibitors. Lancet, 1976, 1, 774.PubMedCrossRefGoogle Scholar
  2. Bell, R. Changing bodies, changing lives: A book for teens on sex and relationships. New York: Random House, 1980.Google Scholar
  3. Brooks-Gunn, J., and Ruble, D. N. Dysmenorrhea in adolescence. Presented to the American Psychologic Association meetings, New York, September, 1979.Google Scholar
  4. Budoff, P. W. Use of mefenamic acid in the treatment of primary dysmenorrhea. Journal of the American Medical Association, 1979, 241, 2713.Google Scholar
  5. Chan, W. Y., and Hill, J. C. Determination of menstrual prostaglandin levels in nondysmenorrheic and dysmenorrheic subjects. Prostaglandins, 1978, 15, 365.PubMedCrossRefGoogle Scholar
  6. Chan, W. Y., Dawood, M. Y., and Fuchs, F. Relief of dysmenorrhea with prostaglandin synthetase inhibitor ibuprofen: effect on prostaglandin levels in menstrual fluid. American Journal of Obstetrics and Gynecology, 1979, 135, 102.PubMedGoogle Scholar
  7. Cuskey, W. R. A systems approach to the study of drug abuse. National Institute on Drug Abuse, Psychosocial Branch, July, 1976 (ROI-DA00813).Google Scholar
  8. Douglas, W. W. Autacoids. In A. G. Gilman, L. S. Goodman, and A. Gilman (Eds.), The Pharmacological Basis of Therapeutics. 6th ed. New York: Macmillan, 1980, 608.Google Scholar
  9. Gardner-Loulan, J., Lopez, B., and Quackenbush, M. Period. California: New Glide, 1979.Google Scholar
  10. Golub, L. J., Lang, W. R., and Menduke, H. The incidence of dysmenorrhea in high school girls. Postgraduate Medical Journal, 1958, 23, 38.Google Scholar
  11. Gough, H. G. Personality factors related to reported severity of menstrual distress. Journal of Abnormal Psychology, 1975, 84, 59.PubMedCrossRefGoogle Scholar
  12. Gross, R. T., and Duke, P. M. The effect of early versus late physical maturation on adolescent behavior. Pediatric Clinics of North America: Adolescent Medicine, 1980, 27, 71–78.Google Scholar
  13. Halbert, D. R., Demers, L. M., and Jones, D. E. Dysmenorrhea and prostaglandins. Obstetrics and Gynecology, 1976, 31, 77.Google Scholar
  14. Klein, J. R., and Litt, I. F. Epidemiology of adolescent dysmenorrhea. Pediatrics, 1981, 68, 66.Google Scholar
  15. Klein, J. R., Litt, I. F., Rosenberg, A., and Udall, L. The effect of aspirin on dysmenorrhea in adolescents. Journal of Pediatrics, 1981, 98, 987.PubMedCrossRefGoogle Scholar
  16. Lundstrom, V. Treatment of primary dysmenorrhea with prostaglandin synthetase inhibitors: A promising therapeutic alternative. Acta Obstetricia et Gynecologica Scandinavica, 1978, 57, 421.CrossRefGoogle Scholar
  17. Lundstrom, V., and Green, K. Endogenous levels of prostaglandins F. and its main metabolites in plasma and endometrium of normal and dysmenorrheic women. American Journal of Obstetrics and Gynecology, 1978, 130, 640.PubMedGoogle Scholar
  18. Moos, R. Menstrual distress questionnaire manual. Stanford, Ca.: Social Ecology Laboratory, Department of Psychiatry and Behavioral Sciences, Stanford University, 1977.Google Scholar
  19. National Center for Health Statistics. Plan and operation of a health examination survey of U.S. youths 12–17 years of age. Public Health Service Pub. No. 1,000, Series 1, No. 8, September 1969.Google Scholar
  20. National Center for Health Statistics. Age at menarche. United States, Series 11, No. 233, 1974.Google Scholar
  21. Novell, H. A. Psychological factors in premenstrual tension. Journal of Clinical Obstetrics and Gynecology, 1965, 1, 222.CrossRefGoogle Scholar
  22. Pickles, V. R. A plain muscle stimulant in the menstrum. Nature, 1957, 180, 1198.PubMedCrossRefGoogle Scholar
  23. Pickles, V. R. Prostaglandins in the human endometrium. International Journal of Fertility, 1967, 12, 335.PubMedGoogle Scholar
  24. Piers, E., and Harris, D. The Piers-Harris children’s self-concept scale. Nashville, Tennessee: Counselor Recording and Tests, 1969.Google Scholar
  25. Pulkkinen, M. O., and Kaihola, H. L. Mefenamic acid in dysmenorrhea. Acta Obstetricia et Gynecologica Scandinavica, 1977, 56, 75.PubMedCrossRefGoogle Scholar
  26. Rauh, J. L. Maturational age and its clinical applications. In J. R. Gallagher, F. P. Heald, and D. C. Garell (Eds.), Medical care of the adolescent, 3d ed. New York: Appleton-Century Crofts, 1976, 25.Google Scholar
  27. Ruble, D. N. Premenstrual symptoms: A reinterpretation. Science,1977, 197(4300),291.Google Scholar
  28. Ruble, D. N., and Brooks-Gunn, J. A developmental analysis of menstrual distress in adolescence. In R. C. Friedman (Ed.), Behavior and the menstrual cycle. New York: Marcel-Dekker, 1982, in press.Google Scholar
  29. Shangold, M. M., Aksel, S., Schomberg, D. W., and Hammond, C. B. Plasma prostaglandin F2,, levels in dysmenorrheic women. Fertility and Sterility, 1976, 27, 1171.PubMedGoogle Scholar
  30. Starfield, B., Gross, E., Wood, M., Pantell, R., Allen, C., Gordon, B. I., Moffatt, P., Drachman, R., and Katz, H. Psychosocial and psychosomatic diagnoses in primary care of children. Pediatrics, 1980, 66, 159.PubMedGoogle Scholar
  31. Tanner, J. M. Growth at adolescence. 2d ed. Oxford, England: Blackwell Scientific, 1962.Google Scholar
  32. Thorpe, L. P., Clark, W. W., and Tiegs, E. Q. Manual, The California test of personality. Monterey, Ca.: McGraw-Hill, 1953.Google Scholar
  33. Vane, J. R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature (New Biology), 1971, 231, 232.Google Scholar
  34. Widholm, O. Dysmenorrhea during adolescence. Acta Obstetricia et Gynecologica Scandinavica, Supplement, 1979, 87, 61.Google Scholar
  35. Ylikorkala, O., and Dawood, M. W. New concepts in dysmenorrhea. American Journal of Obstetrics and Gynecology, 1978, 130, 833.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1983

Authors and Affiliations

  • Jerry R. Klein
    • 1
  • Iris F. Litt
    • 2
  1. 1.Department of Pediatrics, Division of Adolescent MedicineMichael Reese Hospital, University of Chicago Pritzker School of MedicineChicagoUSA
  2. 2.Department of PediatricsStanford University School of MedicineStanfordUSA

Personalised recommendations